| Babson & Associates Primary Care, Pc | |
|
1331 Prairie Ave Ste 1 Cheyenne WY 82009-4867 | |
| (307) 632-0728 | |
| (307) 632-5268 |
| Full Name | Babson & Associates Primary Care, Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 1331 Prairie Ave Ste 1, Cheyenne, Wyoming |
| Authorized Official Name and Position | Terry Johnson (OFFICE MANAGER) |
| Authorized Official Contact | 3076320728 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Babson & Associates Primary Care, Pc 1331 Prairie Ave Ste 1 Cheyenne WY 82009-4867 Ph: (307) 632-0728 | Babson & Associates Primary Care, Pc 1331 Prairie Ave Ste 1 Cheyenne WY 82009-4867 Ph: (307) 632-0728 |
| NPI Number | 1184639759 |
|---|---|
| Provider Enumeration Date | 07/30/2006 |
| Last Update Date | 11/01/2023 |
| Medicare PECOS PAC ID | 0345223343 |
|---|---|
| Medicare Enrollment ID | O20040610001105 |
News Archive
Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5' end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
When does the wait time for cataract surgery cross over from being inconvenient to affecting health and quality of life, Dr. William Hodge and colleagues report on their systematic review of studies that assessed the relation between wait times for cataract surgery and patient outcomes.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184639759 | NPI | - | NPPES |
| 115910100 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Maria Mullikin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417226994 PECOS PAC ID: 7012176852 Enrollment ID: I20120314000144 |
News Archive
Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5' end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
When does the wait time for cataract surgery cross over from being inconvenient to affecting health and quality of life, Dr. William Hodge and colleagues report on their systematic review of studies that assessed the relation between wait times for cataract surgery and patient outcomes.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 2 days ago
| Provider Name | Douglas Edgren |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1033145164 PECOS PAC ID: 6608943006 Enrollment ID: I20150205001773 |
News Archive
Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5' end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
When does the wait time for cataract surgery cross over from being inconvenient to affecting health and quality of life, Dr. William Hodge and colleagues report on their systematic review of studies that assessed the relation between wait times for cataract surgery and patient outcomes.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 2 days ago
| Provider Name | Marianne Denton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952936932 PECOS PAC ID: 0345667036 Enrollment ID: I20200826001463 |
News Archive
Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5' end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
When does the wait time for cataract surgery cross over from being inconvenient to affecting health and quality of life, Dr. William Hodge and colleagues report on their systematic review of studies that assessed the relation between wait times for cataract surgery and patient outcomes.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 2 days ago
| Provider Name | Brittany Jones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497446983 PECOS PAC ID: 5193184612 Enrollment ID: I20230630002329 |
News Archive
Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5' end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
When does the wait time for cataract surgery cross over from being inconvenient to affecting health and quality of life, Dr. William Hodge and colleagues report on their systematic review of studies that assessed the relation between wait times for cataract surgery and patient outcomes.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 2 days ago
| Provider Name | Nicole Turner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285410423 PECOS PAC ID: 3971958018 Enrollment ID: I20231010003206 |
News Archive
Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5' end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
When does the wait time for cataract surgery cross over from being inconvenient to affecting health and quality of life, Dr. William Hodge and colleagues report on their systematic review of studies that assessed the relation between wait times for cataract surgery and patient outcomes.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 2 days ago
| Provider Name | Rachell Raeann Borges |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477246247 PECOS PAC ID: 2860847811 Enrollment ID: I20231011000122 |
News Archive
Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5' end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
When does the wait time for cataract surgery cross over from being inconvenient to affecting health and quality of life, Dr. William Hodge and colleagues report on their systematic review of studies that assessed the relation between wait times for cataract surgery and patient outcomes.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 2 days ago
News Archive
Now, a new study published on the preprint server bioRxiv in July 2020 shows that the 5' end of the RNA molecule is capable of inhibiting the binding of mRNA to the ribosomal 40S subunit, thus preventing translation.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.
When does the wait time for cataract surgery cross over from being inconvenient to affecting health and quality of life, Dr. William Hodge and colleagues report on their systematic review of studies that assessed the relation between wait times for cataract surgery and patient outcomes.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.
› Verified 2 days ago
Healthreach Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2030 Bluegrass Cir, Cheyenne, WY 82009 Phone: 307-635-3500 Fax: 307-635-2199 | |
University Of Wyoming Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 820 E 17th St, Cheyenne, WY 82001 Phone: 307-777-7911 Fax: 307-777-7911 | |
North Cheyenne Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6015 Sycamore Rd, 1st Floor, Cheyenne, WY 82009 Phone: 307-514-1300 | |
Crossroads Healthcare Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 Central Ave, Ste 100, Cheyenne, WY 82007 Phone: 307-632-8064 Fax: 307-632-6131 | |
Clinical Decision Medical Services, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1807 Capitol Ave, Suite 201, Cheyenne, WY 82001 Phone: 307-286-1833 | |
Physician Management Services Of Wyoming, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1331 Prairie Ave Ste 2, Cheyenne, WY 82009 Phone: 888-829-8550 | |
Pauljordanwashburnmd, Llc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5720 Osage Ave, 3-301, Cheyenne, WY 82009 Phone: 970-518-9394 |